| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |